Li and his colleagues also emphasized that CSF cfDNA could reveal the unique genetic profiles of LM and should be considered as the most representative liquid biopsy medium for LM in EGFR-mutant NSCLC (29). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.